氯吡格雷作为抗血小板药物在心脏移植冠状动脉支架置入术中的应用

Clopidogrel as an antiplatelet agent in transplant heart coronary stenting.

作者信息

Mahadevan Vaikom S, Khan Mazhar M, Adgey Jennifer A A

机构信息

Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor Rd., Belfast, BT12 6BA, United Kingdom.

出版信息

J Interv Cardiol. 2002 Jun;15(3):197-9. doi: 10.1111/j.1540-8183.2002.tb01056.x.

DOI:10.1111/j.1540-8183.2002.tb01056.x

PMID:12141144

Abstract

Clopidogrel is increasingly used as an antiplatelet agent along with aspirin in coronary stenting due to its safety profile and clinical efficacy. This report describes a case of successful direct coronary stenting in a transplanted heart with the use of clopidogrel and aspirin therapy. Vessel patency was preserved with no evidence of in stent restenosis on 4-month follow-up angiography.

摘要

由于氯吡格雷的安全性和临床疗效，它在冠状动脉支架置入术中越来越多地与阿司匹林一起用作抗血小板药物。本报告描述了一例在移植心脏中使用氯吡格雷和阿司匹林治疗成功进行直接冠状动脉支架置入术的病例。在4个月的随访血管造影中，血管通畅得以维持，没有支架内再狭窄的证据。